Sources | Names Used |
---|---|
CCLE, GDSC1000, GRAY, FIMM | Sorafenib |
CTRPv2 | sorafenib |
PharmacoGx | Sorafenib |
Database | Identifier |
---|---|
Smiles: | CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F |
Inchikey: | MLDQJTXFUGDVEO-UHFFFAOYSA-N |
Pubchem: | 216239 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MYO1F | GDSC1000 | pan-cancer | AAC | 0.35 | 2e-09 |
mRNA | DNAJC5B | CCLE | pan-cancer | AAC | 0.29 | 2e-09 |
mRNA | CD33 | GDSC1000 | pan-cancer | AAC | 0.33 | 2e-09 |
mRNA | ADGRE2 | GDSC1000 | pan-cancer | AAC | 0.33 | 2e-09 |
mRNA | SIGLEC7 | GDSC1000 | pan-cancer | AAC | 0.31 | 2e-09 |
mRNA | LST1 | GDSC1000 | pan-cancer | AAC | 0.36 | 4e-09 |
mRNA | RNASE6 | CCLE | pan-cancer | AAC | 0.3 | 4e-09 |
mRNA | C1orf228 | CCLE | pan-cancer | AAC | 0.29 | 4e-09 |
mRNA | PIWIL4 | CCLE | pan-cancer | AAC | 0.28 | 4e-09 |
mRNA | C3AR1 | CCLE | pan-cancer | AAC | 0.29 | 6e-09 |